TransMedics CEO buys $2M shares at $118 in August amid...
Key Takeaways TransMedics’ CEO executed significant insider buying in August 2025 at approximately $118 per share, reflecting internal confidence amid strong Q2 results. The company reported Q2 2025 revenue of...